Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 50228-338

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 50228-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion HCl Tabs 150mg-1000s (Bupropion 150mg 1000tab)

This is a description of a medication called Wellbutrin. It contains 150mg bupropion hydrochloride, USP. It includes information about the usual dosage and storage specifications. The medication should be kept in a tight, light-resistant container with a child-resistant closure. The manufacturers are ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY. It is a registered trademark of GlaxoSmithKline.*

FDA Label Image

Bupropion HCl Tabs 150mg-30s (Bupropion 150mg 30tab)

FDA Label Image

Bupropion HCl Tabs 150mg-60s (Bupropion 150mg 60tab)

This is a medication description for a tablet containing 150 mg of bupropion hydrochloride, USP. Dosage instructions and storage information are provided. The medication is called WELLBUTRIN® and is a registered trademark of GlaxoSmithKline. The tablet is manufactured by ScieGen Pharmaceuticals, Inc in Hauppauge, NY.*

FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.